Antibody
0102030405
01
ADT1051-Arcitumomab Biosimilar-Anti-CEACAM5/CD66e mAb-Research Grade
2025-05-21
CEACAM5 engages in homophilic interactions to promote metastatic niche formation and binds heterophilically to receptors like CEACAM1 on T cells, suppressing antitumor immunity by inhibiting lympho...
- Catalog Number ADT1051
- Host CHO Cells
- Species Human
- Target CEACAM5/CD66e
- Application Functional assay, IF, Neut, ELISA, FC, IP, ICC
Inquiry
detail
02
ADT1154-cT84.66 Biosimilar-Anti-CEACAM5/CD66e mAb-Research Grade
2025-05-21
CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5), also known as CD66e, is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein belonging to the CEACAM family.
- Catalog Number ADT1154
- Host CHO Cells
- Species Human
- Target CEACAM5/CD66e
- Application Elisa, WB
Inquiry
detail
03
ADT1127-Cergutuzumab Amunaleukin Biosimilar-(CEACAM5/CEA/CD66e)-Research Biosimilar Antibody
2025-05-21
CEACAM5 contains a single IgV-like domain followed by six IgC2-like domains, with extensive glycosylation contributing to its antigenic and functional diversity.
- Catalog Number ADT1127
- Host CHO Cells
- Species Human
- Target CEACAM5/CEA/CD66e
- Application ELISA, WB
Inquiry
detail
04
ADT1675-Tusamitamab Biosimilar-(CEACAM5/CEA/CD66e)-Research Biosimilar Antibody
2025-05-21
CEACAM5 engages in homophilic interactions to promote metastatic niche formation and binds heterophilically to receptors like CEACAM1 on T cells, suppressing antitumor immunity by inhibiting lympho...
- Catalog Number ADT1675
- Host CHO Cells
- Species Mouse
- Target CEACAM5/CEA/CD66e
- Application ELISA, FCM, BLI, SPR, Functional assay
Inquiry
detail
05
ADT1089-Besilesomab Biosimilar-(CEACAM8/CD66b)-Research Biosimilar Antibody
2025-05-21
CEACAM5 engages in homophilic interactions to promote metastatic niche formation and binds heterophilically to receptors like CEACAM1 on T cells, suppressing antitumor immunity by inhibiting lympho...
- Catalog Number ADT1089
- Host CHO Cells
- Species Human
- Target CEACAM8/CD66b
- Application WB, ELISA, IP, FC, Functional assay, Neut, IF
Inquiry
detail
06
ADT1338-Lampalizumab Biosimilar-(CFD)-Research Biosimilar Antibody
2025-05-21
Complement Factor D, a serine protease cleaving factor B in the alternative complement pathway. Regulates inflammatory responses and tissue damage.
- Catalog Number ADT1338
- Host CHO Cells
- Species Human
- Target CFD
- Application ELISA, IP, FC, Functional assay, Neut, IF, Stim
Inquiry
detail
07
ADT1439-Nimacimab Biosimilar-(CNR1)-Research Biosimilar Antibody
2025-05-21
Cannabinoid Receptor 1, a G-protein-coupled receptor in the central nervous system. Mediates effects of endocannabinoids and THC. Linked to pain, appetite, and addiction.
- Catalog Number ADT1439
- Host CHO Cells
- Species Human
- Target CNR1
- Application ELISA, WB
Inquiry
detail
08
ADT1041-Anti SARS-CoV-2(2019-nCoV) RBD Casirivimab(REGN10933) Biosimilar-(Covid Spike RBD)-Research Biosimilar Antibody
2025-05-21
The Receptor-Binding Domain (RBD) is a critical region of the SARS-CoV-2 spike (S) protein, enabling viral entry into host cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.
- Catalog Number ADT1041
- Host CHO Cells
- Species Human
- Target Covid Spike RBD
- Application ELISA, WB
Inquiry
detail
09
ADT1042-Anti SARS-CoV-2(2019-nCoV) RBD imdevimab(REGN10987) Biosimilar-(Covid Spike RBD)-Research Biosimilar Antibody
2025-05-21
The Receptor-Binding Domain (RBD) is situated within the S1 subunit of the trimeric spike protein. Its Domains:: Core Structure: Stabilizes the RBD. Receptor-Binding Motif (RBM): Directly interacts...
- Catalog Number ADT1042
- Host CHO Cells
- Species Human
- Target Covid Spike RBD
- Application ELISA, WB
Inquiry
detail
10
ADT1066-Bamlanivimab（LY-CoV555） Biosimilar-(Covid Spike RBD)-Research Biosimilar Antibody
2025-05-21
The Receptor-Binding Domain (RBD) is a critical region of the SARS-CoV-2 spike (S) protein, enabling viral entry into host cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.
- Catalog Number ADT1066
- Host CHO Cells
- Species Human
- Target Covid Spike RBD
- Application ELISA, WB
Inquiry
detail
11
ADT1133-Cilgavimab(AZD1061) Biosimilar-(Covid Spike RBD)-Research Biosimilar Antibody
2025-05-21
The Receptor-Binding Domain (RBD) is situated within the S1 subunit of the trimeric spike protein. Its Domains:: Core Structure: Stabilizes the RBD. Receptor-Binding Motif (RBM): Directly interacts...
- Catalog Number ADT1133
- Host CHO Cells
- Species Human
- Target Covid Spike RBD
- Application ELISA, WB
Inquiry
detail
12
ADT1226-Etesevimab(JS016) Biosimilar-(Covid Spike RBD)-Research Biosimilar Antibody
2025-05-21
The Receptor-Binding Domain (RBD) is a critical region of the SARS-CoV-2 spike (S) protein, enabling viral entry into host cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.
- Catalog Number ADT1226
- Host CHO Cells
- Species Human
- Target Covid Spike RBD
- Application ELISA, WB
Inquiry
detail